Menu Menu Menu Login Login Log in Search Search Search

Kite Pharma Inc (KITE) USD0.001

Sell:$179.33 Buy:$179.35 Change: $0.40 (0.22%)
NASDAQ:0.36%
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Kite Pharma Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline 27 Sep 2017
Details (last updated 13 Sep 2017)

As you may be aware the Boards of Kite Pharma Inc and Dodgers Merger Sub Inc, a wholly owned subsidiary of Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Kite Pharma Inc Shares have been offered USD180.00 for each Share held.

What are my options?

Option 1 – Do nothing. You are not required to take any action at this time.

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD180.00 for each Kite Pharma Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

The Hargreaves Lansdown client deadline is noon on Wednesday 27 September 2017.
 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above. 

×
Sell:$179.33
Buy:$179.35
Change: $0.40 (0.22%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Kite Pharma Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline 27 Sep 2017
Details (last updated 13 Sep 2017)

As you may be aware the Boards of Kite Pharma Inc and Dodgers Merger Sub Inc, a wholly owned subsidiary of Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Kite Pharma Inc Shares have been offered USD180.00 for each Share held.

What are my options?

Option 1 – Do nothing. You are not required to take any action at this time.

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD180.00 for each Kite Pharma Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

The Hargreaves Lansdown client deadline is noon on Wednesday 27 September 2017.
 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above. 

×
Sell:$179.33
Buy:$179.35
Change: $0.40 (0.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
Takeover

Kite Pharma Inc USD0.001

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline 27 Sep 2017
Details (last updated 13 Sep 2017)

As you may be aware the Boards of Kite Pharma Inc and Dodgers Merger Sub Inc, a wholly owned subsidiary of Gilead Sciences Inc recently announced the terms of a Tender Offer. Under the terms of the Tender Offer holders of Kite Pharma Inc Shares have been offered USD180.00 for each Share held.

What are my options?

Option 1 – Do nothing. You are not required to take any action at this time.

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD180.00 for each Kite Pharma Inc Share held. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer.

The Hargreaves Lansdown client deadline is noon on Wednesday 27 September 2017.
 

Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above. 

×
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
$179.50
Trade high:
$179.60
Year high:
$179.78
Market capitalisation
Market cap.
:
$10.28 bn
Previous close:
n/a
Trade low:
$179.24
Year low:
$39.83
Shares in issue
Shares
:
57.18 m
Previous:
$0.00 (0.00%)
Previous:
$0.00
Volume:
n/a
Dividend yield:
n/a
Currency:
USD
Data delayed by at least 15 minutes.
* To buy US shares you must first complete and return a US government ‘W-8BEN’ form.

Open an easy to manage, low cost dealing account in less than 5 minutes

Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.

More about the Fund & Share Account

Important Documents

There are no documents available for this stock.

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Reuters. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look. Exchange disclaimer
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.